General practice data and electronic clinical decision support - Issues Paper consultation
Overview
The Department of Health is undertaking a two-stage consultation process to inform thinking around primary health care data and the use of electronic clinical decision support systems in primary health care. The two topics have been combined into a single Issues Paper given the overlap in stakeholders and links between primary health care data and eCDS in the broader health care ecosystem. The combined process will enable stakeholders to consider and share their views regarding one or both policy areas.
This initial consultation will provide information and insights that can then feed into the second stage of consultation, a formal Consultation Regulatory Impact Statement, which will lay out potential regulatory options and seek stakeholder views as to whether there should be formal advice to Government that a regulatory option is justified.
Please find the Issues Paper at the bottom of this page.
Why your views matter
The Department of Health wants to hear from people and organisations who can provide insights into primary health care data and the use of electronic clinical decision support systems in primary health care.
We are seeking feedback on the questions raised in the Issues Paper, as well as any broader insights that submitters would like to include.
Please provide feedback on some or all of the questions rasied. When responding to the questions with specific examples, please provide the appropriate source or evidence for your response.
Thank you for your interest and we look forward to hearing your views.
If you have any questions about how to complete the survey, please email PHN.DWG@health.gov.au
What happens next
Thank you for taking the time to respond to this issues paper. Your feedback will be considered and inform the second stage of this process, a formal Consultation Regulatory Impact Statement.
Audiences
- Anyone from any background
Interests
- e-Health
- Health technology
- Medicare
- Legislation
- Pharmaceutical benefits
- Rural health services
- Regulatory policy
- Chronic disease
- Aboriginal and Torres Strait Islander health
- Preventative health
- Strategic Policy
- Policy Development
Share
Share on Twitter Share on Facebook